A new review finally puts two decades of unpublished fiber data into the citable record. What it puts on the record — and how the publicity around it departs from the paper itself — deserves a careful read.
On July 31, 2026, Archives of Clinical and Biomedical Research published “The Cellular Origin of Morgellons Disease Fibers: A Twenty Year Odyssey” (Middelveen, Fesler, Stricker; ACBR 10(4):224–236, DOI 10.26502/acbr.50170529). It is a narrative review — the authors retracing the fiber-analysis literature from the 2004 Charles E. Holman Foundation fiber study through their own 2020 work — and it arrives with a stated mission: to consolidate the case that Morgellons fibers are human in origin, composed of keratin and collagen, produced by keratinocytes and fibroblasts, and in some cases identifiable as unusually small human hairs.
Readers of this site know we apply the same standard to every source: claims are graded by the evidence behind them, not by which side of the Morgellons debate they land on. By that standard, this review is a genuinely mixed document. It contains interesting unpublished data presented for the first time in citable form. It also blends that data with two decades of personal communications, unpublished observations, and retrospective re-grading of the historical record — without always making clear which category of evidence supports a given claim. And within days of publication, a press release restated the paper’s carefully hedged conclusions as settled fact.
That the field remains unresolved is not this site’s editorial position alone. A 2025 review in Archives of Dermatological Research (Akbarialiabad, Salehi, Murrell & Jafferany; 317:815) — authored outside both research programs in this dispute — concluded after screening 167 studies that Morgellons etiology remains debated, that no randomized controlled trials of Morgellons treatment exist, and that the absence of standardized diagnostic criteria and outcome measures is a central obstacle to progress. That independent baseline is worth holding in mind while reading a review written entirely by one research group about its own program.
The evidence at a glance
Before getting into the review’s new material, it helps to separate several claims that are frequently bundled together in discussions of Morgellons. They do not all rest on evidence of equal strength. The assessments below are ours, ordered from strongest to weakest support, using a consistent scale: well established, good evidence, suggestive, plausible, not established.
| Claim | Our assessment | What the evidence currently supports |
|---|---|---|
| Loose fibers can be contaminated by textiles and environmental material | Well established | Any study relying on loose or surface-collected material faces a substantial contamination problem. Collection method matters enormously. |
| Some patients have non-textile filaments embedded in or projecting from skin | Good evidence | Multiple microscopy and histology reports document fibers associated with tissue rather than simply lying loose on the skin surface — though within specimens collected and selected largely by one research network. |
| Some embedded fibers contain keratin and collagen and appear continuous with skin cells | Good evidence | Published staining studies support keratin and collagen composition and an endogenous cutaneous origin in studied specimens. Independent recruitment and blinded replication remain limited. |
| Blue fiber coloration comes from pigment rather than structural coloration | Good evidence | TEM observation of disorganized melanosomes, the absence of nanostructuring, melanin staining, and broad-band reflectance all point the same way. This is the narrower and better-supported half of the coloration question. |
| The melanin in those fibers is structurally altered | Suggestive | The reported Raman peak pattern would be consistent with altered melanin, but the traces have never been published, and instrument, background, and sample-context effects are not excluded. |
| Borrelia is associated with Morgellons in at least some studied patients | Suggestive | Several studies from the same research network report serological, molecular, histological, or immunostaining evidence of Borrelia. The association deserves further study but lacks broad independent replication. |
| Keratinocyte or fibroblast activity is altered in Morgellons tissue | Plausible | Histological findings are compatible with altered cellular activity, but the regulatory mechanism proposed to explain abnormal filament production has not been demonstrated molecularly. |
| Morgellons can currently be defined and diagnosed using standardized criteria | Not established | There is still no universally accepted case definition, validated diagnostic test, or consensus outcome measure for identifying Morgellons and separating it from overlapping dermatological and systemic presentations. |
| Borrelia causes Morgellons fiber formation | Not established | An association and a proposed biological mechanism are not the same as causation. Prospective, independently replicated evidence connecting infection directly to filament formation is still needed. |
This distinction matters because the strongest evidence in the Morgellons literature concerns a relatively narrow question — whether at least some characteristic embedded filaments can be biological products of skin tissue. That finding does not automatically settle the broader questions of disease identity, infectious association, or causation.
What the 2026 Morgellons fiber review actually adds
Most of the review’s ground is familiar: the 2011 bovine digital dermatitis comparison, the 2012 and 2013 keratin/collagen histology studies, the 2016 Congo red birefringence work, and the 2019–2020 immunohistochemistry detecting Borrelia burgdorferi and Helicobacter pylori antigens within fibers. Those papers exist independently and can be evaluated on their own terms. The genuinely new material is concentrated in two places.
The Robert Smith study (Northern Arizona University, 2006). This is the review’s centerpiece. According to the account — reconstructed from 2025 email correspondence with Smith, then a chemistry master’s student — fibers from a single Morgellons subject were examined by SEM (showing cuticular scaling and a root terminus — hair-consistent morphological features, though morphology alone does not establish a human rather than another mammalian origin), resisted dissolution in guanidine HCl, urea, and TRIzol, and after mechanical grinding yielded two bands on electrophoresis: one at roughly 60 kDa, reportedly identified by mass spectrometry as human serum albumin and human cytoskeletal keratin II, and one at roughly 30 kDa that matched no known human protein in the databases searched. The review reports that this 30 kDa component exhibited the same fluorescence spectral signature as the intact fibers — implying it may be the source of the autofluorescence reported in Morgellons fibers since 2004.
Precision matters here. Until the underlying mass-spectrometry data are available for inspection, the 30 kDa finding is an unidentified electrophoretic band with a reported fluorescence property — not a confirmed novel protein. Bands at that position can reflect degradation products, modified forms of known proteins, protein–pigment complexes, or database-coverage gaps circa 2006. What makes the claim valuable is not its strength but its testability: an unidentified fluorescent ~30 kDa component in properly collected embedded fibers is the kind of finding that modern LC-MS/MS could confirm or refute in a single well-run analysis. It is also, at present, a twenty-year-old unpublished result from one subject, described secondhand through correspondence, with no gel image, no spectra, and no methods section. Both statements are true simultaneously, and neither should be allowed to erase the other.
The Shawkey laboratory data (University of Akron, 2014). The review publishes the fuller account of TEM/SEM and spectroscopy performed on blue fibers embedded in submitted skin samples: hair-consistent morphology with cuticular scaling, disorganized melanosomes, no nanostructuring (arguing against structural coloration), and unusually small fiber diameters. The review itself is imprecise on the measurements, reporting 12–14 µm by SEM, 12–15 µm for TEM cross-sections, and 10–12 µm elsewhere in the same discussion — all well below the 17–181 µm range the review cites for human hair, so the figures disagree with each other while agreeing that these fibers are extraordinarily fine. Raman spectroscopy is also described as showing single major peaks corresponding to eumelanin and pheomelanin where the reference spectra the authors cite report three major peaks for each pigment — a discrepancy the authors interpret as melanin with altered molecular structure.
The spectroscopic framework here is legitimate: Raman characterization of eumelanin and pheomelanin by their characteristic bands is established methodology, and the cited reference for the expected peak positions is a real vibrational-spectroscopy study. But the interpretation being offered — structurally altered melanin, mechanism unknown — is a strong claim resting on spectra no reader can examine. Biological Raman measurements are notoriously sensitive to fluorescence background (a particular problem for melanin, which is itself fluorescent under some excitation conditions), to instrument configuration and excitation wavelength, and to the sample context — pigment measured inside keratinized tissue is not pigment measured as purified standard. Missing peaks can reflect any of these before they reflect altered molecular structure. Publishing the actual traces would let spectroscopists evaluate the claim; describing them in prose, sourced to a 2014 email, does not.
There is also a structural issue that applies to the Akron work and much of the program it belongs to. An outside laboratory analyzing specimens is valuable — but when those specimens are selected and supplied by the originating investigators, it is external analysis, not independent replication. A full independent replication would require independent patient recruitment, independent specimen selection under a pre-specified protocol, and independent analysis. The review does not document a study that clearly meets that full bar. That limitation is broader than the unpublished status of any single finding: patient recruitment and specimen selection remain concentrated within the same research network, and the twenty-year record described here does not include a full independent replication beginning with recruitment and ending with blinded analysis.
The figures. All six figures sit in the section covering the 2004 Haverty study, but Figures 3 and 4A–C show trichrome-style keratin/collagen differential staining and Fontana-Masson melanin staining of sectioned callus material — techniques associated with the group’s later published workflow rather than with the 2004 study as originally described. The paper does not state when these sections were prepared or stained, or on which specimens. Whether they represent original 2004 work, later analysis of archived material, or something else is a question the paper leaves open. We contacted the corresponding author seeking clarification. As of August 14, 2026, no response has been received. Notably, none of the paper’s most consequential new claims is illustrated: the Smith gel, the fluorescence spectra, the Raman traces, and the TEM melanosome images are all described in prose only.
The sourcing problem
Count the source categories in this review and a pattern emerges. Peer-reviewed findings sit alongside several others: unpublished observations attributed to Middelveen (2013, 2016), email correspondence from Smith (2025) and Shawkey (2014), and personal communications from Cindy Casey (2025, 2026) — the director of the Charles E. Holman Morgellons Disease Foundation, which funded the paper’s publication fees and the original 2004 study.
There is nothing improper about a review incorporating unpublished data; reviews do this routinely, and the authors label their sources. The problem is distributional. Several of the review’s most consequential claims — the 30 kDa component, the altered-melanin interpretation, the assertion that red fibers do autofluoresce (contradicting the 2004 study’s published finding), the explanation for why Oklahoma State’s fiber work was compromised — rely on the unpublished and correspondence categories. The peer-reviewed record supports the narrower claims: keratin and collagen composition of embedded fibers, hair-consistent morphology in some specimens, melanin staining patterns.
A reader who takes the abstract at face value (“rigorous chemical, molecular, microscopic, and spectroscopic analyses confirm…”) will not detect this stratification. A reader who traces every citation will. That gap between the summary and the sourcing is exactly the kind of thing this site exists to map — and it applies with equal force whether the paper’s conclusions are ultimately right or wrong.
The intramural reckoning with Wymore
One of the review’s most striking sections is its treatment of Randy Wymore, the Oklahoma State pharmacologist who was for years the most visible academic researcher sympathetic to Morgellons patients. The review recounts Wymore’s own 2012 conference figures — 97% of collected fibers conclusively identified, roughly three-quarters of them cellulose or synthetic textiles — and then argues that his loose-fiber collection methodology made environmental contamination highly likely, that the Tulsa Crime Lab / FBI database comparison is unreliable because the fibers may have been chemically altered before submission, and that his findings “inadvertently lent support” to the contamination and self-implantation account they were meant to challenge.
Two observations. First, the collection-method critique is internally consistent and is the strongest analytical through-line in the paper: the case that only fibers embedded in or protruding from skin should count is well argued, and it cuts against the CDC study and Wymore alike. Second, the retroactive re-grading is asymmetric in its application. The 2004 study’s four subjects are sorted — via 2025 personal communication — into two reliable and two contaminated. Wymore’s entire fiber program is reframed as insufficient for identifying authentic embedded fibers. Negative or ambiguous historical results are repeatedly attributed to bad collection; supportive findings are generally retained. The methodological principle may be sound, but a principle applied only in one direction functions as a filter, not a standard. The genuinely even-handed version of this argument would also ask which of the supportive early findings fail the embedded-fiber test.
The CDC critique: a real difference in questions asked
The review’s dissection of the 2012 CDC study by Pearson et al. will be familiar to readers of our earlier analysis, “Same Name, Different Patients: Why Morgellons Studies Keep Contradicting Each Other.” Some of its objections are worth taking seriously: the fiber analysis was restricted to birefringent material; and while the paper reports 62 biopsies across the biopsy program and, separately, 23 fiber or material specimens collected from intact skin sites in 12 case-patients, it does not present the patient-level relationship between those two sampling groups — how many of the 31 eligible participants contributed biopsies, or how far the biopsy and surface-collection groups overlapped — nor does it describe the morphological form of the birefringent materials found. Procedural contamination during collection is also a fair methodological question. The review also faults the CDC’s reporting that collected materials were “largely composed of protein (83%), likely superficial skin or cellulose consistent with cotton fibers (43%),” asserting that this phrasing makes neither grammatical nor mathematical sense. The mathematical half of that criticism overshoots: specimens containing mixtures of materials can produce overlapping category percentages, so nothing in the numbers is internally contradictory. The sentence is awkwardly constructed, and the relationship between the percentages and the specimen counts is genuinely unclear — but neither flaw amounts to a mathematical contradiction, and that is the part of the review’s characterization that does not hold.
The stronger and more honest framing of the disagreement is this. Pearson’s team examined two distinct datasets: birefringent material found in 16 of 37 lesional biopsies — generally located in the superficial scale-crust, at the tissue’s edge, or separate from it — and, separately, the 23 fiber or material specimens collected from intact skin sites in 12 case-patients. So the CDC did examine tissue, not merely surface debris. The fair criticism is definitional: the embedded-fiber standard the Middelveen group later formalized asks a substantially different question — not “what materials are present on or in the skin of affected patients?” but “what are the fibers that are embedded in or growing from the skin?” A study designed around the first question cannot settle the second, and vice versa. That framing preserves the legitimate critique of the CDC study’s scope without requiring the inference — which the review states as conclusion — that no authentic Morgellons fibers were present in the CDC’s samples. That remains an assumption imported from a definition the CDC study never used.
The paper versus the press release
On August 4, an EIN Presswire release announced the publication. The paper’s own conclusion asks for “enthusiastic, objective, and open-minded investigation” and repeatedly flags open questions — the mechanism of pigment alteration, the identity of the fluorescent component, the role of microorganisms. The press release describes the research as having “changed our understanding of Morgellons disease from a psychiatric illness to an infection-related skin disorder,” quotes Middelveen saying she “cannot understand how anyone could try to pass this infectious process off as delusional,” and calls the venue “the prestigious Archives of Clinical and Biomedical Research.”
On the venue, the verifiable facts are these. The National Library of Medicine’s catalog record for ACBR states that the journal is not currently indexed for MEDLINE, and that PubMed contains selected citations only — per the catalog record, citations for articles whose manuscripts were deposited in PubMed Central in compliance with public access policies. The 5.8 “impact factor” displayed on the journal’s pages is attributed to journalsimpactfactors.com; we could not verify a Clarivate Journal Citation Reports listing. The journal states that it operates single-blind peer review, and this paper’s submission-to-publication interval was twelve days (received July 19, accepted July 24, published July 31). A short interval is not itself proof that review was defective — some legitimate journals move quickly — but it is a fact readers are entitled to weigh, particularly for a review article whose central new claims cannot be checked against the underlying primary data. None of this bears on whether the paper’s content is right. It leaves “prestigious” as promotional language rather than a conclusion supported by standard indexing or citation metrics.
The deeper issue is the rhetorical collapse. Inside the manuscript, infection is one hypothesis among several for the pigment anomalies, and the gene-regulation mechanism is explicitly described as awaiting molecular study. In the publicity, the causal interpretation is presented as settled and continued skepticism as unreasonable. This is the same paper-to-press-release inflation we have documented in coverage skeptical of Morgellons patients — and the standard has to run both ways. Researchers who correctly fault the media for flattening the CDC study into “Morgellons is delusional” should not flatten their own hedged review into “Morgellons is infectious.” The 2025 Archives of Dermatological Research review shows what the uninflated version sounds like: etiology debated, no treatment RCTs, no consensus criteria, standardization needed before causal claims can be adjudicated.
What would actually move this forward
Strip away the framing disputes and the review leaves behind a short list of claims that are specific enough to test. Each is stated concretely enough that a well-designed study could confirm, refine, or refute it — which is more than can be said for most of what has been written about Morgellons fibers on either side:
- The 30 kDa component. If archived material or fresh specimens exist, modern LC-MS/MS on properly collected embedded fibers could identify or exclude an unknown fluorescent component. This is arguably the highest-value replication target in the Morgellons fiber literature — provided the replication is independent in recruitment, collection, and analysis, not another round of externally analyzed, investigator-supplied specimens.
- The Raman spectra. Publishing the actual traces from the Akron work — or repeating the measurement with appropriate melanin standards and fluorescence-background controls — would convert an unpublished report into inspectable experimental evidence, and would let the altered-melanin interpretation be evaluated against the more mundane explanations first.
- The embedded-fiber standard, applied prospectively and symmetrically. A pre-registered collection protocol specifying embedded or protruding fibers only, adopted by independent research groups, would directly address the contamination dispute that has persisted for twenty years. This is also precisely the standardization gap the 2025 independent review identified as the field’s central obstacle.
- The provenance of the retrospective figures. Stating when the 2004-era specimens were sectioned and stained would cost a sentence and buy credibility.
The review closes by asking that Morgellons fibers be met with scientific curiosity rather than ridicule. That is a fair ask, and this site has made the same one. Curiosity, though, is not the opposite of skepticism — it is what skepticism looks like when it is applied honestly in every direction. The most curious thing anyone could do with this paper is attempt to independently replicate its best claim. The least curious thing is to issue a press release declaring the question closed.
MorgellonsSurvey.org reviewed the full text of Middelveen, Fesler & Stricker (2026), the full text of Pearson et al. (2012), the NLM catalog record for Archives of Clinical and Biomedical Research (NLM ID 101768967), the Akbarialiabad et al. (2025) review in Archives of Dermatological Research (DOI 10.1007/s00403-025-04308-6), and the August 4, 2026 EIN Presswire release. The corresponding author was contacted regarding figure provenance. As of August 14, 2026, no response has been received.
